Anakinra/cladribine/cyclophosphamideLack of efficacy and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1885卷 / 1期

关键词：

D O I：

10.1007/s40278-021-06810-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：51 / 51

相关论文

共 50 条

[11] DexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1910 (1) : 178 - 178
[12] HydroxychloroquineLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1925 (1) : 264 - 264
[13] AzithromycinLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1878 (1) : 110 - 110
[14] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1943 (1) : 84 - 84
[15] NivolumabLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1945 (1) : 417 - 417
[16] FavipiravirLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1980 (1) : 175 - 175
[17] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1857 (1) : 44 - 44
[18] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1883 (1) : 45 - 45
[19] TocilizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2025, 2042 (1) : 455 - 455
[20] AlectinibLack of efficacy and off-label use: case report
Reactions Weekly, 2024, 2032 (1) : 25 - 25

← 1 2 3 4 5 →